FDA Adverse Event Injury Summary report: N

ENDEAVOR SPRINT RX CORONARY STENT SYSTEM

MDR report key: 1983017 · Received February 7, 2011

Report

Report Number
2953200-2011-00297
Event Type
Injury
Date Received
February 7, 2011
Date of Event
December 3, 2013
Report Date
December 12, 2013
Manufacturer
MEDTRONIC CARDIOVASCULAR GALWAY
Product Code
NIQ
PMA / PMN Number
P060033
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
BR
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). EVALUATION, RESULTS: MI.

Additional Manufacturer Narrative · 1

RESULTS, CONCLUSION: HAEMORRHAGE. (B)(4).

Additional Manufacturer Narrative · 1

CONTINUED FROM CONCOMITANT MEDICAL PRODUCTS: LIPID LOWERING DRUGS. (B)(4): DISSECTION. PATIENT'S AGE AT TIME OF EVENT WAS (B)(6) NOT (B)(6) AS REPORTED IN INITIAL REPORT.

Description of Event or Problem · 1

DURING INDEX PROCEDURE, THE PATIENT HAD 2 ENDEAVOR SPRINT RAPID EXCHANGE (RX) DRUG-ELUTING STENTS IMPLANTED TO THE MID LAD. DURING IMPLANTATION A DISSECTION OCCURRED. IT IS UNKNOWN HOW THE DISSECTION WAS TREATED. (REF MFR # 9612164-2012-00026)

Description of Event or Problem · 1

APPROXIMATELY 36 MONTHS POST INDEX PROCEDURE THE PATIENT WAS HOSPITALIZED DUE TO A GI BLEED. THE PATIENT WAS TREATED WITH MEDICATION AND A TRANSFUSION. ANTIPLATELET MEDICATION WAS STOPPED DUE TO THE EVENT AND RESUMED 4 DAYS POST THE GI BLEED. INVESTIGATOR INDICATED THAT THE REPORTED EVENT WAS NOT RELATED TO THE STUDY DEVICE IT IS REPORTED THAT THE ISSUE IS NOT RESOLVED.

Description of Event or Problem · 1

A 3.0 MM DIAMETER X 18 MM LENGTH ENDEAVOR SPRINT RAPID EXCHANGE (RX) DRUG ELUTING CORONARY STENT WAS DEPLOYED IN THE MID LAD OF A PATIENT WITH NO ISSUES REPORTED. IT WAS REPORTED THAT THE PATIENT HAD AN MI ONE DAY POST IMPLANT OF THE RELEVANT STENT. PROLONGED HOSPITALIZATION WAS REQUIRED. NO OTHER CLINICAL SEQUELAE WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ENDEAVOR SPRINT RX CORONARY STENT SYSTEM NIQ MEDTRONIC CARDIOVASCULAR GALWAY NA 0001031882

Patients

Seq Age Sex Outcome Treatment
1 00071 YR Hospitalization OMEPRAZOL| DAPT| ASA| BETA, ANGIOTENSIN, CA++ ANTAGONIST| CLOPIDOGREL